|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 14 March 2006
doi: 10.1242/jcs.02837
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death
System-Biodynamics NCRC, National Research Laboratory of Molecular Neurophysiology and Division of Molecular and Life Science, Pohang University of Science and Technology, Hyoja dong, San31, Pohang, 790-784, South Korea
* Author for correspondence (e-mail: ktk{at}postech.ac.kr)
Accepted 15 December 2005
Mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) is a dual-specificity phosphatase that is involved in the regulation of cell survival, differentiation and apoptosis through inactivating MAPKs by dephosphorylation. Here, we provide evidence for a role of MKP-1 in the glutamate-induced cell death of HT22 hippocampal cells and primary mouse cortical neurons. We suggest that, during glutamate-induced oxidative stress, protein kinase C (PKC)
becomes activated and induces sustained activation of extracellular signal-regulated kinase 1/2 (ERK1/2) through a mechanism that involves degradation of MKP-1. Glutamate-induced activation of ERK1/2 was blocked by inhibition of PKC
, confirming that ERK1/2 is regulated by PKC
. Prolonged exposure to glutamate caused reduction in the protein level of MKP-1, which correlated with the sustained activation of ERK1/2. Furthermore, knockdown of endogenous MKP-1 by small interfering (si)RNA resulted in pronounced enhancement of ERK1/2 phosphorylation accompanied by increased cytotoxicity under glutamate exposure. In glutamate-treated cells, MKP-1 was polyubiquitylated and proteasome inhibitors markedly blocked the degradation of MKP-1. Moreover, inhibition of glutamate-induced PKC
activation suppressed the downregulation and ubiquitylation of MKP-1. Taken together, these results demonstrate that activation of PKC
triggers degradation of MKP-1 through the ubiquitin-proteasome pathway, thereby contributing to persistent activation of ERK1/2 under glutamate-induced oxidative toxicity.
Key words: Glutamate, MKP-1, Immature cortical neuron, Neuronal cell death, Ubiquitylation, Proteasomal degradation
This article has been cited by other articles:
![]() |
Y. Ho, R. Samarasinghe, M. E. Knoch, M. Lewis, E. Aizenman, and D. B. DeFranco Selective Inhibition of Mitogen-Activated Protein Kinase Phosphatases by Zinc Accounts for Extracellular Signal-Regulated Kinase 1/2-Dependent Oxidative Neuronal Cell Death Mol. Pharmacol., October 1, 2008; 74(4): 1141 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Lomonaco, S. Kahana, M. Blass, Y. Brody, H. Okhrimenko, C. Xiang, S. Finniss, P. M. Blumberg, H.-K. Lee, and C. Brodie Phosphorylation of Protein Kinase C{delta} on Distinct Tyrosine Residues Induces Sustained Activation of Erk1/2 via Down-regulation of MKP-1: ROLE IN THE APOPTOTIC EFFECT OF ETOPOSIDE J. Biol. Chem., June 20, 2008; 283(25): 17731 - 17739. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qi and D. Mochly-Rosen The PKC{delta} -Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis J. Cell Sci., March 15, 2008; 121(6): 804 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lingor, L. Tonges, N. Pieper, C. Bermel, E. Barski, V. Planchamp, and M. Bahr ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells Brain, January 1, 2008; 131(1): 250 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Venugopal, J. Chen, Y. Zhang, D. Clemens, A. Follenzi, and M. A. Zern Role of MAPK Phosphatase-1 in Sustained Activation of JNK during Ethanol-induced Apoptosis in Hepatocyte-like VL-17A Cells J. Biol. Chem., November 2, 2007; 282(44): 31900 - 31908. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhang, V. Anantharam, A. Kanthasamy, and A. G. Kanthasamy Neuroprotective Effect of Protein Kinase C{delta} Inhibitor Rottlerin in Cell Culture and Animal Models of Parkinson's Disease J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 913 - 922. [Abstract] [Full Text] [PDF] |
||||